Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Anesthesiol Clin ; 35(2): 191-205, 2017 Jun.
Article in English | MEDLINE | ID: mdl-28526142

ABSTRACT

Bleeding complications are a common concern with the use of anticoagulant agents. In many situations, reversing of neutralizing their effects may be warranted. Prothrombin complex concentrate replaces coagulation factors lowered by warfarin, as does fresh frozen plasma, but in a more concentrated form. Protamine negates the effect of heparin and combines chemically with heparin molecules to form an inactive salt. It also partially reverses the effects of low-molecular-weight heparin. Recombinant activated factor VII is a nonspecific procoagulant that activates the extrinsic clotting pathway, resulting in thrombin generation, but does not directly neutralize the activity of any of the new oral anticoagulants.


Subject(s)
Anticoagulants , Coagulants/pharmacology , Anesthetics , Antithrombins/pharmacokinetics , Antithrombins/pharmacology , Blood Coagulation Factors/pharmacokinetics , Blood Coagulation Factors/pharmacology , Coagulants/pharmacokinetics , Dabigatran/pharmacokinetics , Dabigatran/pharmacology , Factor VIIa/pharmacokinetics , Factor VIIa/pharmacology , Factor Xa Inhibitors/pharmacokinetics , Factor Xa Inhibitors/pharmacology , Hemorrhage , Humans , Protamines/pharmacokinetics , Protamines/pharmacology , Vitamin K/antagonists & inhibitors
SELECTION OF CITATIONS
SEARCH DETAIL
...